ELISA Kit for Serine Peptidase Inhibitor Kazal Type 1 (SPINK1)

1.56-100ng/mL

The minimum detectable dose of this kit is typically less than 0.61ng/mL

3h

This assay has high sensitivity and excellent specificity for detection of Serine Peptidase Inhibitor Kazal Type 1 (SPINK1).
No significant cross-reactivity or interference between Serine Peptidase Inhibitor Kazal Type 1 (SPINK1) and analogues was observed.

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Serine Peptidase Inhibitor Kazal Type 1 (SPINK1). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Serine Peptidase Inhibitor Kazal Type 1 (SPINK1). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Serine Peptidase Inhibitor Kazal Type 1 (SPINK1), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Serine Peptidase Inhibitor Kazal Type 1 (SPINK1) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer.; Surgical decompression of Wirsung duct reduces serum concentration of SPINK1 in patients with chronic pancreatitis;